$Alaunos Therapeutics (TCRT.US)$ TCR-T Library Phase 1/2 tri...

CR7 On Wall Street commented on a stock · Jan 8 15:23

$Alaunos Therapeutics(TCRT.US)$ TCR-T Library Phase 1/2 trial achievedan 87% disease control rate of eight evaluable patients with metastatic, refractory solid tumors; TCR-T cell therapy was well tolerated in all treated patients

Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more

Translate

Report

3946 Views

Comment

CR7 On Wall Street

28Followers

5Following

211Visitors